Taipei, Taiwan

Chung-Ming Yu

USPTO Granted Patents = 11 

Average Co-Inventor Count = 7.4

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2016-2024

Loading Chart...
11 patents (USPTO):

Title: Innovations of Chung-Ming Yu in Neurodegenerative Disease Treatment

Introduction

Chung-Ming Yu is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of medical science, particularly in the treatment of neurodegenerative diseases. With a total of 11 patents to his name, his work focuses on innovative methods that aim to improve the quality of life for individuals suffering from conditions such as Alzheimer's disease.

Latest Patents

One of his latest patents is titled "Methods of treating neurodegenerative diseases." This patent describes a method for treating neurodegenerative diseases, including Alzheimer's disease, through the use of a monoclonal antibody that binds to the Siglec-3 receptor. The monoclonal antibody enhances the phagocytosis of neurotoxic peptides by immune cells, providing a neuroprotective effect to subjects in need. Another significant patent is "Anti-Siglec antibody, pharmaceutical composition comprising the same, and uses thereof." This patent discloses a novel monoclonal antibody that exhibits binding affinity to the Siglec-3 receptor and is capable of reversing HBV-induced immunosuppression. The uses of this antibody extend to the treatment and prophylaxis of hepatitis B virus infection.

Career Highlights

Chung-Ming Yu has worked at prestigious institutions such as Academia Sinica, where he has contributed to groundbreaking research and development in his field. His work has garnered attention for its potential impact on treating serious health conditions.

Collaborations

Chung-Ming Yu has collaborated with notable colleagues, including An-Suei Yang and Hong-Sen Chen, to advance research in neurodegenerative diseases and related fields.

Conclusion

Chung-Ming Yu's innovative work in the treatment of neurodegenerative diseases showcases his dedication to improving healthcare through scientific advancements. His patents reflect a commitment to finding effective solutions for complex medical challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…